Article Text

Download PDFPDF

Correction: Rhabdomyolysis during high dose interleukin-2 treatment of metastatic melanoma after sequential immunotherapies: a case report

Statistics from Altmetric.com

Clark JI, Bufalino S, Singh S, et al. Rhabdomyolysis during high dose interleukin-2 treatment of metastatic melanoma after sequential immunotherapies: a case report. J Immunother Cancer 2018;6:53. doi: 10.1186/s40425-018-0370-6

Since the online publication of this article, the authors have noticed that I. Caroline Le Poole (caroline.lepoole@northwestern.edu) is missing from the author list. The correct author list and affiliations can be found below:

Joseph I. Clark1, Shams Bufalino2, Shruti Singh1, I. Caroline Le Poole3 and Ewa Borys1

1Cardinal Bernardin Cancer Center, Loyola University Medical Center, 2160 S 1st Avenue, Maywood, IL 60153, USA.

2Advocate Lutheran General Hospital, Park Ridge, IL, USA.

3Lurie Comprehensive Cancer Center, Northwestern University, Chicago

Additionally, the following grant acknowledgement is missing: This work was supported in part by RO1 CA191317 to ICLP.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.